The big problem of small data: A new approach

Big Data is all the rage today, but Small Data matters too! Drawing reliable conclusions from small datasets, like those from clinical trials for rare diseases or in studies of endangered species, remains one of the trickiest ...

Slow-release hydrogel aids immunotherapy for cancer

An immunotherapy drug embedded in a slow-release hydrogel invented at Rice University in collaboration with the University of Texas Health Science Center at Houston (UTHealth) appears to be highly effective at killing cancer ...

New big data approach predicts drug toxicity in humans

Researchers can now predict the odds of experimental drugs succeeding in clinical trials, thanks to a new data-driven approach developed by Weill Cornell Medicine scientists. The method detects toxic side effects that may ...

New method optimizes outcomes for subjects in comparison tests

Clinical trials of new drugs or devices face a problem that most empirical inquiries don't: They must not only provide clear data about toxicity and efficacy but also try to maximize the quality of treatment for all of the ...

page 11 from 26